Evolution of Tumor Model: From Animal Model of Tumor to Tumor Model in Animal

作者: Nandini Dey , Yuliang Sun , Brian Leyland-Jones , Pradip De

DOI: 10.4236/JCT.2013.49168

关键词:

摘要: Patient derived xenograft (PDX) is defined as a growth of patients’ tumor in the setting. The evolution cancer model animal has century old history. most single reason that exerted pressure on traditional to evolve PDX models have not delivered expected and predicted clinical success. In spite well above 50 drugs developed approved for oncology over last several decades, there remains nirking paucity success reminder this war riding far from won. backbreaking attempt analyze failure, limitation “model” system appeared be rational cause shortcoming. It was more failure test drug rather than make stunted our collective research. product age-old its fitness currently tested virtually all organ-type solid tumors. This review will present appraise context evolution, future promise, limitations specifically, current content different tumors including breast, lung, colorectal, prostrate, GBM, pancreatic, hepatocellular carcinoma melanoma.

参考文章(76)
Dustin M. Walters, James M. Lindberg, Sara J. Adair, Timothy E. Newhook, Catharine R. Cowan, Jayme B. Stokes, Cheryl A. Borgman, Edward B. Stelow, Bryce T. Lowrey, Maria E. Chopivsky, Tona M. Gilmer, John T. Parsons, Todd W. Bauer, Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib Neoplasia. ,vol. 15, pp. 143- 155 ,(2013) , 10.1593/NEO.121712
Mingxia Yan, Ming Yao, Chao Ge, Fangyu Zhao, Jinjun Li, Lixing Zhang, Hong Li, Establishment of NOD/SCID mouse models of human hepatocellular carcinoma via subcutaneous transplantation of histologically intact tumor tissue Chinese Journal of Cancer Research. ,vol. 25, pp. 289- 298 ,(2013) , 10.3978/J.ISSN.1000-9604.2013.05.02
Hongbo Zhu, Wei Zhou, Jingzi Hu, Zhongting Huang, Weifeng Lao, Xuefeng Huang, Chao He, Suppressing the growth of rectal cancer xenografts derived from patient tumors by an adenovector expressing small hairpin RNA targeting Bcl-XL. Journal of Gene Medicine. ,vol. 14, pp. 761- 768 ,(2012) , 10.1002/JGM.2681
C. O. Povlsen, J. Visfeldt, J. Rygaard, Grethe Jensen, Growth patterns and chromosome constitutions of human malignant tumours after long-term serial transplantation in nude mice. Acta Pathologica Microbiologica Scandinavica Section A Pathology. ,vol. 83, pp. 709- 716 ,(2009) , 10.1111/J.1699-0463.1975.TB01401.X
Mengmeng Yang, Baoen Shan, Qiaoxia Li, Xiaoming Song, Jie Cai, Jianyun Deng, Likun Zhang, Zhenjian Du, Junjie Lu, Taiping Chen, Jean-Pierre Wery, Yiyou Chen, Qixiang Li, Overcoming erlotinib resistance with tailored treatment regimen in patient-derived xenografts from naïve Asian NSCLC patients International Journal of Cancer. ,vol. 132, pp. E74- E84 ,(2013) , 10.1002/IJC.27813
Cécile Laurent, David Gentien, Sophie Piperno-Neumann, Fariba Némati, André Nicolas, Bruno Tesson, Laurence Desjardins, Pascale Mariani, Audrey Rapinat, Xavier Sastre-Garau, Jérôme Couturier, Philippe Hupé, Leanne de Koning, Thierry Dubois, Sergio Roman-Roman, Marc-Henri Stern, Emmanuel Barillot, J William Harbour, Simon Saule, Didier Decaudin, None, Patient-derived xenografts recapitulate molecular features of human uveal melanomas Molecular Oncology. ,vol. 7, pp. 625- 636 ,(2013) , 10.1016/J.MOLONC.2013.02.004
Pierre Guerreschi, Camille Scalbert, Ahmad Qassemyar, Jerome Kluza, Laura Ravasi, Damien Huglo, Veronique Martinot-Duquennoy, Pierre Formstecher, Philippe Marchetti, Laurent Mortier, Patient-derived tumor xenograft model to guide the use of BRAF inhibitors in metastatic melanoma Melanoma Research. ,vol. 23, pp. 373- 380 ,(2013) , 10.1097/CMR.0B013E328363ED92
John J. Tentler, Aik Choon Tan, Colin D. Weekes, Antonio Jimeno, Stephen Leong, Todd M. Pitts, John J. Arcaroli, Wells A. Messersmith, S. Gail Eckhardt, Patient-derived tumour xenografts as models for oncology drug development Nature Reviews Clinical Oncology. ,vol. 9, pp. 338- 350 ,(2012) , 10.1038/NRCLINONC.2012.61
Andrea Bertotti, Giorgia Migliardi, Francesco Galimi, Francesco Sassi, Davide Torti, Claudio Isella, Davide Corà, Federica Di Nicolantonio, Michela Buscarino, Consalvo Petti, Dario Ribero, Nadia Russolillo, Andrea Muratore, Paolo Massucco, Alberto Pisacane, Luca Molinaro, Emanuele Valtorta, Andrea Sartore-Bianchi, Mauro Risio, Lorenzo Capussotti, Marcello Gambacorta, Salvatore Siena, Enzo Medico, Anna Sapino, Silvia Marsoni, Paolo M Comoglio, Alberto Bardelli, Livio Trusolino, None, A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discovery. ,vol. 1, pp. 508- 523 ,(2011) , 10.1158/2159-8290.CD-11-0109